Nepal Journal of Epidemiology https://www.nepjol.info/index.php/NJE <p>The official journal of the International Nepal Epidemiological Association (INEA). Content also available on the journal's own <a title="NJE" href="http://www.ceainea.org" target="_blank" rel="noopener">website</a>. It is indexed in PubMed,PubMed Central, EMBASE, Web of Science, Thomson and Reuters, CABI.</p> International Nepal Epidemiological Association (INEA) en-US Nepal Journal of Epidemiology 2091-0800 <ul><li>Upon acceptance Copyright on any research article is transferred in full to the Confederation of Epidemiological Associations (CEA) and International Nepal Epidemiological Association (INEA). The copyright transfer includes the right to reproduce and distribute the article in any form of reproduction (printing, electronic media or any other form).</li><li>Articles in the Nepal Journal of Epidemiology are Open Access articles published under the Creative Commons CC BY License (<a href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</a>)</li><li>This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.</li></ul> Treatment of Long COVID or Post COVID syndrome: A pharmacological approach https://www.nepjol.info/index.php/NJE/article/view/48532 <p>The novel virus SARS-CoV-2 has plagued our earth for more than a quarter of a decade and is still currently a limiting factor in our daily lives. Of late a new dilemma is beginning to incapacitate a large populous who have been infected by the virus, this condition being termed as post COVID syndrome or Long COVID.Long COVID is becoming more prolific and common amongst those infected with COVID-19 and its development in patients does not delineate between those who have suffered from a symptomatic or an asymptomatic preliminary infection. The effect of this post COVID syndrome can be multisystemic in nature and can affect the daily cognitive abilities of the individual. It is therefore pertinent and of the upmost importance that therapeutic options against Long COVID are explored as the incidence of this condition is rising and will continue to do so in future.&nbsp;</p> <p>Currently no definitive treatment against Long COVID has been approved and the mainstay treatment is divided into Symptomatic, Supportive and Rehabilitative treatment with self-monitoring. The crux of the current treatment trends for Long COVID is that of a multidisciplinary approach with a great portion of the treatment implicating the patient to take an active role in their recovery, self-monitoring and treatment of the syndrome. Hyperbaric oxygen therapy as well as the use of adaptogens has shown promising results and is advisable to be added to the treatment regimen of patients to aid in decreasing fatigue in patients suffering from post-COVID syndrome. The use of melatonin in patients suffering from insomnia and poor sleep hygiene is also advisable.</p> Indrajit Banerjee Jared Robinson Brijesh Sathian Copyright (c) 2022 CEA & INEA http://creativecommons.org/licenses/by/4.0 2022-09-30 2022-09-30 12 3 1220 1223 10.3126/nje.v12i3.48532 Panic buying research: A bibliometric review https://www.nepjol.info/index.php/NJE/article/view/43436 <p><strong>Background</strong>: Panic buying has been reported during a period of crisis when people buy an extra amount of essential commodities and hoard them anticipating their future utility. As a newer entity, a bibliometric analysis would reveal the research gaps for further studies. We aimed to do a bibliometric analysis of researches published on panic buying over the past two decades.</p> <p><strong>Methods: </strong>A literature search was conducted in the SCOPUS database using the keyword “panic buying”. All published research in the English language between 1st January 2001 to 1st August 2021 was included in the analysis of this study.</p> <p><strong>Results: </strong>We identified a total of 142 articles on panic buying published over the past two decades. There is an exponential increase in the publication on this topic during the COVID-19 pandemic (n=127). Majority of the articles were published from the United States (n=23), followed by the United Kingdom (n=20), and China (n=20). The <em>Frontiers in Public Health </em>and <em>Journal of Retailing and Consumer Services </em>published the highest number of articles (eight each). Arafat SMY published the highest number of publications as a single author (n=10) and <em>Enam Medical College and Hospital</em>, Bangladesh has the highest number of papers as an institution (n=10). Among all the publishers, Elsevier has published the maximum number of papers (n=38).</p> <p><strong>Conclusion: </strong>There is an exponential growth of panic buying research during 2020-21. The global crisis of the COVID-19 pandemic has been attributed to the recent rise in panic buying research.</p> SM Yasir Arafat Sujita Kumar Kar Rakesh Singh Vikas Menon Brijesh Sathian Russell Kabir Copyright (c) 2022 CEA & INEA http://creativecommons.org/licenses/by/4.0 2022-09-30 2022-09-30 12 3 1224 1230 10.3126/nje.v12i3.43436